-
1
-
-
0032913909
-
Fractionation and protraction for radiotherapy of prostate carcinoma
-
10.1016/S0360-3016(98)00438-6, 10192361
-
Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:1095-1101. 10.1016/S0360-3016(98)00438-6, 10192361.
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.43
, pp. 1095-1101
-
-
Brenner, D.J.1
Hall, E.J.2
-
2
-
-
0038724753
-
What hypofractionated protocols should be tested for prostate cancer?
-
10.1016/S0360-3016(03)00132-9, 12829147
-
Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 2003, 56:1093-1104. 10.1016/S0360-3016(03)00132-9, 12829147.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 1093-1104
-
-
Fowler, J.F.1
Ritter, M.A.2
Chappell, R.J.3
Brenner, D.J.4
-
3
-
-
34248594934
-
Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?
-
Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?. Clin Oncol (R Coll Radiol) 2007, 19:289-301.
-
(2007)
Clin Oncol (R Coll Radiol)
, vol.19
, pp. 289-301
-
-
Dasu, A.1
-
4
-
-
73349139882
-
Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials
-
10.1007/s12094-009-0382-2, 19574201
-
Macias V, Biete A. Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials. Clin Transl Oncol 2009, 11:437-445. 10.1007/s12094-009-0382-2, 19574201.
-
(2009)
Clin Transl Oncol
, vol.11
, pp. 437-445
-
-
Macias, V.1
Biete, A.2
-
5
-
-
1542267898
-
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds
-
10.1097/01.ju.0000113299.34404.22, 14767279
-
Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004, 171:1098-1104. 10.1097/01.ju.0000113299.34404.22, 14767279.
-
(2004)
J Urol
, vol.171
, pp. 1098-1104
-
-
Grills, I.S.1
Martinez, A.A.2
Hollander, M.3
Huang, R.4
Goldman, K.5
Chen, P.Y.6
Gustafson, G.S.7
-
6
-
-
78049478731
-
High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer
-
10.1097/COC.0b013e3181b9cd2f, 19952715
-
Martinez AA, Demanes J, Vargas C, Schour L, Ghilezan M, Gustafson GS. High-Dose-Rate Prostate Brachytherapy: An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer. Am J Clin Oncol 2010, 33(5):481-8. 10.1097/COC.0b013e3181b9cd2f, 19952715.
-
(2010)
Am J Clin Oncol
, vol.33
, Issue.5
, pp. 481-488
-
-
Martinez, A.A.1
Demanes, J.2
Vargas, C.3
Schour, L.4
Ghilezan, M.5
Gustafson, G.S.6
-
7
-
-
33747176013
-
High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer
-
10.1016/j.radonc.2006.06.011, 16870289
-
Yoshioka Y, Konishi K, Oh RJ, Sumida I, Yamazaki H, Nakamura S, Nishimura K, Nonomura N, Okuyama A, Inoue T. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiother Oncol 2006, 80:62-68. 10.1016/j.radonc.2006.06.011, 16870289.
-
(2006)
Radiother Oncol
, vol.80
, pp. 62-68
-
-
Yoshioka, Y.1
Konishi, K.2
Oh, R.J.3
Sumida, I.4
Yamazaki, H.5
Nakamura, S.6
Nishimura, K.7
Nonomura, N.8
Okuyama, A.9
Inoue, T.10
-
8
-
-
77952573123
-
CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance
-
10.1089/end.2009.0438, 20433370
-
Aluwini S, van Rooij P, Hoogeman M, Bangma C, Kirkels WJ, Incrocci L, Kolkman-Deurloo IK. CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance. J Endourol 2010, 24:865-869. 10.1089/end.2009.0438, 20433370.
-
(2010)
J Endourol
, vol.24
, pp. 865-869
-
-
Aluwini, S.1
van Rooij, P.2
Hoogeman, M.3
Bangma, C.4
Kirkels, W.J.5
Incrocci, L.6
Kolkman-Deurloo, I.K.7
-
9
-
-
70349308343
-
Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer
-
Friedland JL, Freeman DE, Masterson-McGary ME, Spellberg DM. Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 2009, 8:387-392.
-
(2009)
Technol Cancer Res Treat
, vol.8
, pp. 387-392
-
-
Friedland, J.L.1
Freeman, D.E.2
Masterson-McGary, M.E.3
Spellberg, D.M.4
-
10
-
-
40949091902
-
Virtual HDR(SM) CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations
-
10.1016/j.ijrobp.2007.11.067, 18374232
-
Fuller DB, Naitoh J, Lee C, Hardy S, Jin H. Virtual HDR(SM) CyberKnife Treatment for Localized Prostatic Carcinoma: Dosimetry Comparison With HDR Brachytherapy and Preliminary Clinical Observations. Int J Radiat Oncol Biol Phys 2008, 70:1588-1597. 10.1016/j.ijrobp.2007.11.067, 18374232.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.70
, pp. 1588-1597
-
-
Fuller, D.B.1
Naitoh, J.2
Lee, C.3
Hardy, S.4
Jin, H.5
-
11
-
-
77749338092
-
Stereotactic body radiotherapy for organ-confined prostate cancer
-
10.1186/1471-2490-10-1, 2831888, 20122161
-
Katz AJ, Santoro M, Ashley R, Diblasio F, Witten M. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010, 10:1. 10.1186/1471-2490-10-1, 2831888, 20122161.
-
(2010)
BMC Urol
, vol.10
, pp. 1
-
-
Katz, A.J.1
Santoro, M.2
Ashley, R.3
Diblasio, F.4
Witten, M.5
-
12
-
-
61349144278
-
Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
-
10.1016/j.ijrobp.2008.05.059, 18755555
-
King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 2009, 73:1043-1048. 10.1016/j.ijrobp.2008.05.059, 18755555.
-
(2009)
Int J Radiat Oncol Biol Phys
, vol.73
, pp. 1043-1048
-
-
King, C.R.1
Brooks, J.D.2
Gill, H.3
Pawlicki, T.4
Cotrutz, C.5
Presti, J.C.6
-
13
-
-
33847248003
-
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results
-
10.1016/j.ijrobp.2006.10.050, 17336216
-
Madsen BL, Hsi RA, Pham HT, Fowler JF, Esagui L, Corman J. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007, 67:1099-1105. 10.1016/j.ijrobp.2006.10.050, 17336216.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 1099-1105
-
-
Madsen, B.L.1
Hsi, R.A.2
Pham, H.T.3
Fowler, J.F.4
Esagui, L.5
Corman, J.6
-
14
-
-
78651469971
-
Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer
-
Townsend NC, Huth BJ, Ding W, Garber B, Mooreville M, Arrigo S, Lamond J, Brady LW. Acute toxicity after CyberKnife-delivered hypofractionated radiotherapy for treatment of prostate cancer. Am J Clin Oncol 2010,
-
(2010)
Am J Clin Oncol
-
-
Townsend, N.C.1
Huth, B.J.2
Ding, W.3
Garber, B.4
Mooreville, M.5
Arrigo, S.6
Lamond, J.7
Brady, L.W.8
-
15
-
-
0025313292
-
Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984)
-
10.1016/0090-4295(90)80207-4, 2385876
-
Lloyd-Davies RW, Collins CD, Swan AV. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990, 36:107-111. 10.1016/0090-4295(90)80207-4, 2385876.
-
(1990)
Urology
, vol.36
, pp. 107-111
-
-
Lloyd-Davies, R.W.1
Collins, C.D.2
Swan, A.V.3
-
16
-
-
50449083967
-
Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT
-
10.1118/1.2968333, 18841856
-
Hossain S, Xia P, Chuang C, Verhey L, Gottschalk AR, Mu G, Ma L. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 2008, 35:4041-4048. 10.1118/1.2968333, 18841856.
-
(2008)
Med Phys
, vol.35
, pp. 4041-4048
-
-
Hossain, S.1
Xia, P.2
Chuang, C.3
Verhey, L.4
Gottschalk, A.R.5
Mu, G.6
Ma, L.7
-
17
-
-
77955927836
-
Dose gradient gear target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer
-
Hossain S, Xia P, Huang K, Descovich M, Chuang C, Gottschalk AR, Roach M, Ma L. Dose gradient gear target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010,
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
Hossain, S.1
Xia, P.2
Huang, K.3
Descovich, M.4
Chuang, C.5
Gottschalk, A.R.6
Roach, M.7
Ma, L.8
-
18
-
-
49549093853
-
Intrafractional motion of the prostate during hypofractionated radiotherapy
-
10.1016/j.ijrobp.2008.04.051, 2725181, 18722274
-
Xie Y, Djajaputra D, King CR, Hossain S, Ma L, Xing L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:236-246. 10.1016/j.ijrobp.2008.04.051, 2725181, 18722274.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 236-246
-
-
Xie, Y.1
Djajaputra, D.2
King, C.R.3
Hossain, S.4
Ma, L.5
Xing, L.6
-
19
-
-
0028969271
-
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
-
10.1016/0360-3016(95)00060-C, 7713792
-
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 31:1341-1346. 10.1016/0360-3016(95)00060-C, 7713792.
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.31
, pp. 1341-1346
-
-
Cox, J.D.1
Stetz, J.2
Pajak, T.F.3
-
20
-
-
37449026934
-
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer
-
10.1002/cncr.23139, 17968996
-
Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 2008, 112:55-60. 10.1002/cncr.23139, 17968996.
-
(2008)
Cancer
, vol.112
, pp. 55-60
-
-
Abramowitz, M.C.1
Li, T.2
Buyyounouski, M.K.3
Ross, E.4
Uzzo, R.G.5
Pollack, A.6
Horwitz, E.M.7
-
21
-
-
0030769192
-
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV
-
D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys 1997, 39:335-340.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.39
, pp. 335-340
-
-
D'Amico, A.V.1
Whittington, R.2
Kaplan, I.3
Beard, C.4
Schultz, D.5
Malkowicz, S.B.6
Tomaszewski, J.E.7
Wein, A.8
Coleman, C.N.9
-
22
-
-
0037099725
-
Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
-
D'Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002, 95:281-286.
-
(2002)
Cancer
, vol.95
, pp. 281-286
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
Cote, K.4
Loffredo, M.5
Schultz, D.6
Chen, M.H.7
Tomaszewski, J.E.8
Renshaw, A.A.9
Wein, A.10
Richie, J.P.11
-
23
-
-
0032538069
-
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
-
D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Jama 1998, 280:969-974.
-
(1998)
Jama
, vol.280
, pp. 969-974
-
-
D'Amico, A.V.1
Whittington, R.2
Malkowicz, S.B.3
Schultz, D.4
Blank, K.5
Broderick, G.A.6
Tomaszewski, J.E.7
Renshaw, A.A.8
Kaplan, I.9
Beard, C.J.10
Wein, A.11
-
24
-
-
0030758727
-
Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?
-
10.1016/S0360-3016(97)00123-5, 9240638
-
Keyser D, Kupelian PA, Zippe CD, Levin HS, Klein EA. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: radiation therapy or surgery?. Int J Radiat Oncol Biol Phys 1997, 38:723-729. 10.1016/S0360-3016(97)00123-5, 9240638.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 723-729
-
-
Keyser, D.1
Kupelian, P.A.2
Zippe, C.D.3
Levin, H.S.4
Klein, E.A.5
-
25
-
-
0346363495
-
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer
-
10.1016/S0360-3016(03)00784-3, 14697417
-
Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004, 58:25-33. 10.1016/S0360-3016(03)00784-3, 14697417.
-
(2004)
Int J Radiat Oncol Biol Phys
, vol.58
, pp. 25-33
-
-
Kupelian, P.A.1
Potters, L.2
Khuntia, D.3
Ciezki, J.P.4
Reddy, C.A.5
Reuther, A.M.6
Carlson, T.P.7
Klein, E.A.8
-
26
-
-
0034650685
-
A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution
-
10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z, 10640977
-
Martinez AA, Gonzalez JA, Chung AK, Kestin LL, Balasubramaniam M, Diokno AC, Ziaja EL, Brabbins DS, Vicini FA. A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution. Cancer 2000, 88:425-432. 10.1002/(SICI)1097-0142(20000115)88:2<425::AID-CNCR25>3.0.CO;2-Z, 10640977.
-
(2000)
Cancer
, vol.88
, pp. 425-432
-
-
Martinez, A.A.1
Gonzalez, J.A.2
Chung, A.K.3
Kestin, L.L.4
Balasubramaniam, M.5
Diokno, A.C.6
Ziaja, E.L.7
Brabbins, D.S.8
Vicini, F.A.9
-
27
-
-
80755146969
-
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
-
King CR, Brooks JD, Gill H, Presti JCJ. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010,
-
(2010)
Int J Radiat Oncol Biol Phys
-
-
King, C.R.1
Brooks, J.D.2
Gill, H.3
Presti, J.C.J.4
-
28
-
-
70350515452
-
Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma
-
10.1016/j.radonc.2009.09.001, 19800702
-
Aizer AA, Yu JB, Colberg JW, McKeon AM, Decker RH, Peschel RE. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma. Radiother Oncol 2009, 93:185-191. 10.1016/j.radonc.2009.09.001, 19800702.
-
(2009)
Radiother Oncol
, vol.93
, pp. 185-191
-
-
Aizer, A.A.1
Yu, J.B.2
Colberg, J.W.3
McKeon, A.M.4
Decker, R.H.5
Peschel, R.E.6
-
29
-
-
43049168349
-
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes
-
10.1016/j.ijrobp.2007.10.004, 18164858
-
Cahlon O, Zelefsky MJ, Shippy A, Chan H, Fuks Z, Yamada Y, Hunt M, Greenstein S, Amols H. Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 2008, 71:330-337. 10.1016/j.ijrobp.2007.10.004, 18164858.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 330-337
-
-
Cahlon, O.1
Zelefsky, M.J.2
Shippy, A.3
Chan, H.4
Fuks, Z.5
Yamada, Y.6
Hunt, M.7
Greenstein, S.8
Amols, H.9
-
30
-
-
0035450305
-
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy
-
Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 2001, 51:31-40.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.51
, pp. 31-40
-
-
Grimm, P.D.1
Blasko, J.C.2
Sylvester, J.E.3
Meier, R.M.4
Cavanagh, W.5
-
31
-
-
0034817278
-
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience
-
10.1016/S0094-0143(05)70163-4, 11590814
-
Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001, 28:555-565. 10.1016/S0094-0143(05)70163-4, 11590814.
-
(2001)
Urol Clin North Am
, vol.28
, pp. 555-565
-
-
Han, M.1
Partin, A.W.2
Pound, C.R.3
Epstein, J.I.4
Walsh, P.C.5
-
32
-
-
27744545777
-
Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes
-
10.1016/j.ijrobp.2005.05.054, 16169683
-
Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005, 63:1463-1468. 10.1016/j.ijrobp.2005.05.054, 16169683.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.63
, pp. 1463-1468
-
-
Kupelian, P.A.1
Thakkar, V.V.2
Khuntia, D.3
Reddy, C.A.4
Klein, E.A.5
Mahadevan, A.6
-
34
-
-
78651491567
-
Stereotactic robotic radiosurgery for localized prostate cancer: Initial evaluation of acute toxicities
-
Ponsky LE, Lillibridge C, Brindle J, Zhang Y, Wessels B, Einstein DB. Stereotactic robotic radiosurgery for localized prostate cancer: Initial evaluation of acute toxicities. 2009 ASCO Annual Meeting. Orlando, Florida 2009,
-
(2009)
2009 ASCO Annual Meeting. Orlando, Florida
-
-
Ponsky, L.E.1
Lillibridge, C.2
Brindle, J.3
Zhang, Y.4
Wessels, B.5
Einstein, D.B.6
-
35
-
-
78651490214
-
Hypofractionated robotic radiosurgery for the treatment of clinically localized prostate cancer: Early biochemical results and acute toxicity
-
Oermann E, Hanscom HS, Lei S, Suy S, Chen V, Collins BT, Dritschilo A, Lynch JH, Dawson NA, Collins SP. Hypofractionated robotic radiosurgery for the treatment of clinically localized prostate cancer: Early biochemical results and acute toxicity. 2010 ASCO Annual Meeting Chicago, IL 2010,
-
(2010)
2010 ASCO Annual Meeting Chicago, IL
-
-
Oermann, E.1
Hanscom, H.S.2
Lei, S.3
Suy, S.4
Chen, V.5
Collins, B.T.6
Dritschilo, A.7
Lynch, J.H.8
Dawson, N.A.9
Collins, S.P.10
|